Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengyuan Capsule
- Development stage
- Phase 4
- Lead developer
- Qiang Fu
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Zhengyuan Capsule is a Traditional Chinese Medicine (TCM) formulation developed by Qiangfu Biotech for the treatment of cancer-related fatigue (CRF). It is specifically being evaluated in patients with breast cancer who have completed primary anti-tumor therapies such as surgery, chemotherapy, or radiotherapy. The capsule is designed to alleviate symptoms of fatigue and improve the overall quality of life by tonifying qi, a central concept in TCM for restoring energy and vitality. A Phase 4 clinical trial (NCT05483400) is currently investigating its effectiveness and safety in this patient population.
- Brand names
- Zhengyuan Capsule
- Other names
- Zhengyuan Jiaonang
Beyond the preview
Go deeper on Zhengyuan Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhengyuan Capsule.